CD80 and neoplasm: The authors proposed that failure to clear apoptotic cells following complement inhibition resulted in an enhanced inflammatory response, characterised by an early increase in tumour neutrophil numbers and subsequent higher numbers of mature dendritic cells (CD11C+, CD86+, CD80+) and CD8+ T cells in tumours treated with the combination [45].